These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9258971)

  • 1. Valproate-induced liver failure in one of two siblings with Alpers disease.
    Schwabe MJ; Dobyns WB; Burke B; Armstrong DL
    Pediatr Neurol; 1997 May; 16(4):337-43. PubMed ID: 9258971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders.
    Saneto RP; Lee IC; Koenig MK; Bao X; Weng SW; Naviaux RK; Wong LJ
    Seizure; 2010 Apr; 19(3):140-6. PubMed ID: 20138553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure.
    Delarue A; Paut O; Guys JM; Montfort MF; Lethel V; Roquelaure B; Pellissier JF; Sarles J; Camboulives J
    Pediatr Transplant; 2000 Feb; 4(1):67-71. PubMed ID: 10731063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity.
    Bicknese AR; May W; Hickey WF; Dodson WE
    Ann Neurol; 1992 Dec; 32(6):767-75. PubMed ID: 1471867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that Alpers-Huttenlocher syndrome could be a mitochondrial disease.
    Rasmussen M; Sanengen T; Skullerud K; Kvittingen EA; Skjeldal OH
    J Child Neurol; 2000 Jul; 15(7):473-7. PubMed ID: 10921519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpers syndrome: progressive neuronal degeneration of children with liver disease.
    Gordon N
    Dev Med Child Neurol; 2006 Dec; 48(12):1001-3. PubMed ID: 17109792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features.
    Wolf NI; Rahman S; Schmitt B; Taanman JW; Duncan AJ; Harting I; Wohlrab G; Ebinger F; Rating D; Bast T
    Epilepsia; 2009 Jun; 50(6):1596-607. PubMed ID: 19054397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage.
    Kayihan N; Nennesmo I; Ericzon BG; Németh A
    Pediatr Transplant; 2000 Aug; 4(3):211-4. PubMed ID: 10933322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive cerebral degeneration of childhood with liver disease (Alpers Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation.
    Wörle H; Köhler B; Schlote W; Winkler P; Bastanier CK
    Clin Neuropathol; 1998; 17(2):63-8. PubMed ID: 9561326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive neuronal degeneration of childhood (Alpers syndrome) with hepatic cirrhosis.
    Wilson DC; McGibben D; Hicks EM; Allen IV
    Eur J Pediatr; 1993 Mar; 152(3):260-2. PubMed ID: 8444257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers-Huttenlocher syndrome: report of two cases].
    Castro-Gago M; González-Conde V; Fernández-Seara MJ; Rodrigo-Sáez E; Fernández-Cebrián S; Alonso-Martín A; Campos Y; Arenas J; Eirís-Puñal J
    Rev Neurol; 1999 Nov 16-30; 29(10):912-7. PubMed ID: 10637838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene.
    Pronicka E; Weglewska-Jurkiewicz A; Pronicki M; Sykut-Cegielska J; Kowalski P; Pajdowska M; Jankowska I; Kotulska K; Kalicinski P; Jakobkiewicz-Banecka J; Wegrzyn G
    Med Sci Monit; 2011 Apr; 17(4):CR203-9. PubMed ID: 21455106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    König SA; Schenk M; Sick C; Holm E; Heubner C; Weiss A; König I; Hehlmann R
    Epilepsia; 1999 Jul; 40(7):1036-40. PubMed ID: 10403231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease.
    Cardenas JF; Amato RS
    Semin Pediatr Neurol; 2010 Mar; 17(1):62-4. PubMed ID: 20434700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the neuronal vulnerability underpinning Alpers' syndrome: a clinical and neuropathological study.
    Hayhurst H; Anagnostou ME; Bogle HJ; Grady JP; Taylor RW; Bindoff LA; McFarland R; Turnbull DM; Lax NZ
    Brain Pathol; 2019 Jan; 29(1):97-113. PubMed ID: 30021052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
    Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
    Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketogenic diet in Alpers-Huttenlocher syndrome.
    Joshi CN; Greenberg CR; Mhanni AA; Salman MS
    Pediatr Neurol; 2009 Apr; 40(4):314-6. PubMed ID: 19302948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity.
    Stewart JD; Horvath R; Baruffini E; Ferrero I; Bulst S; Watkins PB; Fontana RJ; Day CP; Chinnery PF
    Hepatology; 2010 Nov; 52(5):1791-6. PubMed ID: 21038416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation.
    Hynynen J; Komulainen T; Tukiainen E; Nordin A; Arola J; Kälviäinen R; Jutila L; Röyttä M; Hinttala R; Majamaa K; Mäkisalo H; Uusimaa J
    Liver Transpl; 2014 Nov; 20(11):1402-12. PubMed ID: 25065347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.